Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PLA2G3 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → PLA2G3 |
| (<<) CDC42EP1 → PLA2G3 |
| (<<) EP300 → PLA2G3 |
| (<<) GBP2 → PLA2G3 |
| (<<) GRPEL1 → PLA2G3 |
| (<<) HMGCR → PLA2G3 |
| (<<) IDI1 → PLA2G3 |
| (<<) KLF2 → PLA2G3 |
| (<<) MUC2 → PLA2G3 |
| (<<) POP1 → PLA2G3 |
| (<<) RPS6KB2 → PLA2G3 |
| (<<) SQLE → PLA2G3 |
| (<<) STAT5A → PLA2G3 |
| (<<) TAF9 → PLA2G3 |
| (<<) THBS1 → PLA2G3 |
| Downstream (Children) |
|---|
| PLA2G3 → GRIN1 (>>) |
| PLA2G3 → HIPK1 (>>) |
| PLA2G3 → KLF7 (>>) |
| PLA2G3 → KRTAP1-3 (>>) |
| PLA2G3 → MREG (>>) |
| PLA2G3 → SYN1 (>>) |
